Raymond James Financial Inc Pacira Bio Sciences, Inc. Transaction History

Raymond James Financial Inc

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2025 Aug 14, 2025	BUY	$22.91 - $27.14 $1.75 Million - $2.07 Million	76,411 Added 557.87%	90,108 $2.15 Million
Q1 2025 May 13, 2025	BUY	$18.33 - $27.25 $65,951 - $98,045	3,598 Added 35.63%	13,697 $340,000
Q4 2024 Feb 06, 2025	BUY	$15.3 - $20.33 $154,514 - $205,312	10,099 New	10,099 $190,000

260

48.9M

118K

63.7K

Ticker PCRX
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 45,824,200
Market Cap $1.09B
Description
Pacira BioSciences, Inc. provides non-opioid pain management and regenerative health solutions for healthcare practitioners and their patients in the United States. The company offers EXPAREL, a bupivacaine liposome injectable suspension; ZILRETTA, a triamcinolone acetonide extended-release injectable suspension; and iovera system, a non-opioid ...

Get notified when there are updates to the investment portfolio of Raymond James Financial Inc, based on Form 13F filings with the SEC.

Stay updated on Raymond James Financial Inc with notifications on news.